Evidence map›Paper›PMID 17710135›Full record

ArticlePloS one2007

Loss of receptor on tuberculin-reactive T-cells marks active pulmonary tuberculosis.

Mathias Streitz, Lydia Tesfa, Vedat Yildirim, Ali Yahyazadeh, Timo Ulrichs, Rodica Lenkei, Ali Quassem, Gerd Liebetrau, Laurel Nomura, Holden Maecker and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 81 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. TheFuture virology · 2020
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. High Frequencies of Caspase-3 ExpressingFrontiers in immunology · 2018
    Article
  17. Study of CD27 and CCR4 Markers on Specific CD4Frontiers in immunology · 2018
    Article
  18. Article
  19. Article
  20. Analysis of the Phenotype ofFrontiers in immunology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Mathias StreitzInstitut für Medizinische Immunologie der Charité, Charité Universitätsmedizin Berlin, Berlin, Germany.
Lydia Tesfa
Vedat Yildirim
Ali Yahyazadeh
Timo Ulrichs
Rodica Lenkei
Ali Quassem
Gerd Liebetrau
Laurel Nomura
Holden Maecker
Hans-Dieter Volk
Florian Kern
Charité - Universitätsmedizin Berlin · DEBD Biosciences (United States) · USOrtenau Klinikum · DEMax Planck Institute for Infection Biology · DESaint Göran Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTuberculin-specific T-cell responses have low diagnostic specificity in BCG vaccinated populations. While subunit-antigen (e.g. ESAT-6, CFP-10) based tests are useful for diagnosing latent tuberculosis infection, there is no reliable immunological test for active pulmonary tuberculosis. Notably, all existing immunological tuberculosis-tests are based on T-cell response size, whereas the diagnostic potential of T-cell response quality has never been explored. This includes surface marker expression and functionality of mycobacterial antigen specific T-cells. METHODOLOGY/PRINCIPAL

findingsFlow-cytometry was used to examine over-night antigen-stimulated T-cells from tuberculosis patients and controls. Tuberculin and/or the relatively M. tuberculosis specific ESAT-6 protein were used as stimulants. A set of classic surface markers of T-cell naïve/memory differentiation was selected and IFN-gamma production was used to identify T-cells recognizing these antigens. The percentage of tuberculin-specific T-helper-cells lacking the surface receptor CD27, a state associated with advanced differentiation, varied considerably between individuals (from less than 5% to more than 95%). Healthy BCG vaccinated individuals had significantly fewer CD27-negative tuberculin-reactive CD4 T-cells than patients with smear and/or culture positive pulmonary tuberculosis, discriminating these groups with high sensitivity and specificity, whereas individuals with latent tuberculosis infection exhibited levels in between. CONCLUSIONS/SIGNIFICANCE: Smear and/or culture positive pulmonary tuberculosis can be diagnosed by a rapid and reliable immunological test based on the distribution of CD27 expression on peripheral blood tuberculin specific T-cells. This test works very well even in a BCG vaccinated population. It is simple and will be of great utility in situations where sputum specimens are difficult to obtain or sputum-smear is negative. It will also help avoid unnecessary hospitalization and patient isolation.

Indexed as

Tuberculosis, PulmonaryTumor Necrosis Factor Receptor Superfamily, Member 7AdolescentAdultAgedAged, 80 and overBCG VaccineBiomarkersCell SeparationCytokinesFemaleFlow CytometryHumansMaleMiddle AgedProspective StudiesBCG VaccineBiomarkersCytokinesTuberculinTumor Necrosis Factor Receptor Superfamily, Member 7

Identifiers

PMID17710135
PMCPMC1936433
OpenAlexW1976123633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.